Summary: Being a morning person and maintaining regular physical activity are linked to a lower risk of developing amyotrophic lateral sclerosis (ALS). In a large preliminary study of more than 500,000 people, participants who identified as morning chronotypes had about a 20% lower risk of ALS than those who favored late-night schedules. Regular, moderate weekly exercise was associated with roughly a 26% lower risk. While the research shows associations rather than proof of causation, the findings suggest that aligning sleep patterns with daylight and staying physically active may contribute to reduced ALS risk.
Key Facts
- Morning chronotype advantage: Individuals who preferred earlier bedtimes and wake times had a 20% lower risk of ALS compared with evening chronotypes.
- Benefit of activity: Achieving at least 600 MET-minutes of physical activity per week (about 150 minutes of brisk walking) was associated with a 26% lower ALS risk.
- Recommended sleep duration: Sleeping six to eight hours per night corresponded to a lower risk compared with sleeping less or more.
- Large prospective dataset: The study followed roughly 500,000 participants for an average of 14 years; during that period 675 people developed ALS.
- Circadian alignment hypothesis: Researchers propose that sleep patterns synchronized with natural daylight may support neuroprotection, though additional research is needed.
Source: AAN
Overview of the study
This preliminary analysis, presented at the American Academy of Neurology’s 78th Annual Meeting, examined associations between sleep timing (chronotype), sleep duration, physical activity, and subsequent ALS risk. The investigators emphasize that the results are observational and do not establish causality.
ALS is a progressive neurodegenerative condition that attacks motor neurons in the brain and spinal cord. It gradually impairs the ability to initiate and control muscle movement, often leading to paralysis and shortened survival; typical life expectancy after diagnosis ranges from two to five years.
The study enrolled more than 500,000 adults with a mean age of 57 and followed them for about 14 years. At baseline, participants answered questionnaires about their regular sleep patterns and physical activity levels. Over the follow-up period, 675 participants (approximately 0.14%) were diagnosed with ALS.
Chronotype and ALS risk
Researchers classified participants by chronotype, which reflects preferred timing for sleep and peak alertness within the 24-hour circadian rhythm. Morning chronotypes (“early birds”) prefer earlier bedtimes and peak productivity in the morning; evening chronotypes (“night owls”) prefer later sleep and peak performance later in the day. In this cohort, 277,620 participants were categorized as early birds and 166,361 as night owls; another 58,298 could not be reliably classified and were excluded from chronotype-specific comparisons.
After adjusting for age, sex, body mass index and other covariates, the analysis found that early birds experienced about a 20% reduced risk of developing ALS compared with night owls. The authors suggest that better alignment of sleep timing with natural light-dark cycles could be one factor influencing neurodegenerative risk, though confounding factors and biological mechanisms remain to be clarified.
Sleep duration
Sleep duration also correlated with ALS risk. Participants reporting six to eight hours of sleep per night had a lower risk of ALS than those who reported shorter or longer nightly sleep, independent of chronotype.
Physical activity and MET calculations
Physical activity was quantified using metabolic equivalents (METs), which measure energy expenditure. Activities were assigned standard MET values—8.0 for vigorous exercise (running, cycling), 4.0 for moderate-intensity tasks (carrying light loads, household chores), and 3.3 for walking. Frequency and duration converted these into MET-minutes per week. The cohort’s average activity level was about 2,645 MET-minutes per week.
Participants who achieved 600 MET-minutes or more weekly (roughly equivalent to 150 minutes of brisk walking) showed a lower incidence of ALS. Among the more active group, 386 of 314,170 developed ALS, while among those below 600 MET-minutes, 107 of 70,946 developed the disease. After adjustment, ≥600 MET-minutes per week was associated with a 26% reduced risk.
Interpretation and limitations
The investigators caution that these observations do not prove that changing sleep timing or increasing activity will prevent ALS. The study’s strengths include its large size and long follow-up; limitations include a predominantly White study population (about 95%), which may limit generalizability to other racial and ethnic groups. Further research is needed to replicate the findings and investigate biological pathways linking circadian patterns, activity, and neurodegeneration.
Funding: The research was supported by a major national-level research program in China.
Frequently Asked Questions
Q: Can being a night owl cause ALS?
A: No. The study identifies an association between evening chronotype and higher ALS risk, but it does not demonstrate causation. Genetics, environment, and other factors also contribute to ALS risk.
Q: How much exercise is needed to see a benefit?
A: The study observed a benefit at 600 MET-minutes per week, roughly equivalent to about 150 minutes of moderate activity such as brisk walking spread across the week, or about 75 minutes of vigorous exercise.
Q: Does sleep duration matter as much as timing?
A: Both appear important. The lowest risk was associated with sleeping six to eight hours per night, suggesting both adequate duration and appropriate timing relative to daylight may be relevant.
Editorial notes
- This article was edited by a Neuroscience News editor.
- The original journal paper was reviewed in full by the editorial team.
- Additional context and clarification were added by staff editors.
About this ALS research news
Author: Renee Tessman
Source: AAN (American Academy of Neurology)
Contact: Renee Tessman – AAN
Image credit: Neuroscience News
Original research presentation: Findings were presented at the American Academy of Neurology’s 78th Annual Meeting.